Unicycive Therapeutics (UNCY) Trading Snapshot
Trading performance
Unicycive Therapeutics (UNCY) closed the 24‑hour period ending 04:08 AM Central Europe on Saturday 24 April 2026 up 1.84 %.
The current trading price is USD 3.89 on major exchanges.
Market data
Shares outstanding: 27.9 million.
Market capitalization: USD 107.8 million.
24‑hour trading volume: USD 5.6 million.
Year‑to‑date change since the end of the previous month: ‑21.98 %.
200‑day simple moving average: USD 6.18.
52‑week high: USD 8.74 (recorded 14 May 2026).
52‑week low: USD 3.35 (recorded 16 October 2026).
Comparison with Peer Stocks (24‑hour Performance)
| Stock | 24‑hour change | Current price (USD) | Market cap (USD) |
|---|---|---|---|
| Bank Of The James (BOTJ) | +3.88 % | 29.73 | 126.4 million |
| Neovolta (NEOV) | +4.35 % | 2.16 | 127.5 million |
| Nkarta (NKTX) | +0.57 % | 1.79 | 125.3 million |
| Organogenesis (ORGO) | –2.84 % | 0.99 | 127.6 million |
| Anavex Life Sciences (AVXL) | 0 % | 1.33 | 126.1 million |
Bank Of The James also reported a price‑to‑earnings ratio of 11.
Company Overview
Unicycive Therapeutics, Inc., headquartered in Los Altos, United States, is a biotechnology firm focused on developing two novel therapies for hyperphosphatemia in patients with chronic kidney disease and acute kidney injury.
